OneChain Immunotherapeutics - Crunchbase Company Profile & Funding

Q: Who invested in OneChain Immunotherapeutics?

OneChain Immunotherapeutics has 6 investors including Centre for the Development of Industrial Technology (CDTI) And Clave Capital.

Q: How much funding has OneChain Immunotherapeutics raised to date?

OneChain Immunotherapeutics has raised obfuscated.

Overview

OneChain Immunotherapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About OneChain Immunotherapeutics

CB Rank

87366

OCI develops therapies for leukaemia based on CAR–T.

Founded

obfuscation

Private

Seed

Barcelona, Catalonia, Spain

11-50

www.onechaintx.com

Biotechnology

Life Science

Funding Rounds

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Pablo Menéndez: President, Founder and CSO
Jorge Alemany Herrera: CEO

Details

Legal Name

ONECHAIN IMMUNOTHERAPEUTICS, S.L

Also Known As

OCI

Operating Status

Active

Company Type

For Profit

Founders

Pablo Menéndez

About the Company

OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.

Predictions & Insights

Growth Insight

See this Growth Insight

OneChain Immunotherapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

OC-1

A CAR-T therapy candidate designed to treat relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma by targeting cancerous T-cells.

Research & Development

OneChain Immunotherapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - OneChain Immunotherapeutics	5	obfuscated obfuscation	Invivo Capital Partners	Seed
obfuscated obfuscation	Seed Round - OneChain Immunotherapeutics	5	obfuscated obfuscation	Invivo Capital Partners	Seed
obfuscated obfuscation	Seed Round - OneChain Immunotherapeutics	5	obfuscated obfuscation	Invivo Capital Partners	Seed
obfuscated obfuscation	Seed Round - OneChain Immunotherapeutics	5	obfuscated obfuscation	Invivo Capital Partners	Seed
obfuscated obfuscation	Seed Round - OneChain Immunotherapeutics	5	obfuscated obfuscation	Invivo Capital Partners	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - OneChain Immunotherapeutics	5	obfuscated obfuscation	Invivo Capital Partners	Seed
obfuscated obfuscation	Seed Round - OneChain Immunotherapeutics	5	obfuscated obfuscation	Invivo Capital Partners	Seed
obfuscated obfuscation	Seed Round - OneChain Immunotherapeutics	5	obfuscated obfuscation	Invivo Capital Partners	Seed
obfuscated obfuscation	Seed Round - OneChain Immunotherapeutics	5	obfuscated obfuscation	Invivo Capital Partners	Seed
obfuscated obfuscation	Seed Round - OneChain Immunotherapeutics	5	obfuscated obfuscation	Invivo Capital Partners	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Centre for the Development of Industrial Technology (CDTI)	—	Seed Round - OneChain Immunotherapeutics	—
Centre for the Development of Industrial Technology (CDTI)	—	Seed Round - OneChain Immunotherapeutics	—
Centre for the Development of Industrial Technology (CDTI)	—	Seed Round - OneChain Immunotherapeutics	—
Centre for the Development of Industrial Technology (CDTI)	—	Seed Round - OneChain Immunotherapeutics	—
Centre for the Development of Industrial Technology (CDTI)	—	Seed Round - OneChain Immunotherapeutics	—